IL6 and chronic obstructive pulmonary disease: Various experiments on the effects of NPs on lung disorders, such as asthma, COPD, and other lung diseases, indicated that nanoparticles suppressed proinflammatory mediators, such as IL-6, IL-8, IL-1β, and TNF-α.